Cordis Optease & Trapease IVC Filter Lawsuits
There are a growing number of Cordis IVC filter lawsuits being filed in California state court over problems with the OptEase and TrapEase devices.
Cordis Corporation makes the OptEase and TrapEase IVC filters, which are designed to prevent pulmonary embolisms Unfortunately, recent studies have found alarming rates of filter fracture, perforation, migration, and tilting when the filters are not removed after a few months.
Contact Dr Shezad Malik Law Firm, We Can Help
The Dr Shezad Malik Law Firm is currently accepting Cordis OptEase and TrapEase IVC filter injury cases nationwide. If you or somebody you know was injured by an IVC filter that broke or moved, you should contact our lawyers immediately for a free case consultation. Please use the form to contact our law firm or call toll free 24 hours a day at 888-210-9693 ext. 2.
What are Cordis IVC Filters?
Cordis Corporation makes two temporary IVC filters, the OptEase and TrapEase. These devices are implanted in the inferior vena cava (IVC) to block blood clots from the leg before they cause pulmonary embolism.
Cordis IVC Filter FDA Approval
Cordis IVC filters are designed to be temporary, and they were approved with a FDA 510(k) process that said they were “equivalent” to the Bard Recovery IVC filter, which was recalled in 2005, and the Cook Günther Tulip.
Both of these Bard and Cook filters have been associated with high rates of filter fracture, perforation, migration, and tilting.
Temporary vena cava filters can cause severe complications when they are not removed. The rates of filter fracture, perforation, migration, and tilting increase the longer they remain implanted.
FDA Filter Warnings
In 2011, the FDA recommended removing IVC filters within 29 and 54 days after implantation. In 2008, the agency also issued a Safety Warnings after receiving over 900 adverse events involving complications, such as:
- Filter fracture
- Embolization of broken components
- Migration and tilt
- Organ damage (heart, lungs, kidneys, intestines)
- Perforation of the vena cava
- Internal hemorrhage (bleeding)
- Deep Vein Thrombosis (DVT)
- Filter or broken parts embedded
The FDA recommends that implanting physicians and clinicians responsible for the ongoing care of patients with retrievable IVC filters consider removing the filter as soon as protection from pulmonary embolism is no longer needed.
A patient should be referred for IVC filter removal when the risk/benefit profile favors removal and the procedure is feasible given the patient’s health status.
Cordis IVC Filter Linked to 50% Fracture Risk
A Japanese study in November 2011 found that 10 out of 20 patients who were implanted with the Cordis TrapEase IVC filters had a fractured strut within 50 months of implantation.
Cordis IVC Filter 2013 Recall
In March 2013, Cordis issued a Class 1 recall for about 33,000 OptEase IVC filters due to a labeling error that could cause the filter to be implanted backwards. If the fixation barbs are pointing in the wrong direction, there would be nothing to stop the filter from migrating to the patient’s heart.
IVC Filter Lawsuits
Over 1,300 Bard, Cook and Cordis IVC filter lawsuits have been filed as of August 2016. These lawsuits have been centralized in federal court — about 709 have been filed against C.R. Bard in Arizona (MDL No. 2641) and about 654 more have been filed against Cook Medical in Illinois (MDL No. 2570).
Cordis IVC filter lawsuits have been centralized in Alameda County, California, the home of Cordis corporation. To date over 100 lawsuits have been filed in California.
Cordis IVC Filter Lawsuit? Contact Dr Shezad Malik Law Firm
The Dr Shezad Malik Law Firm is currently accepting Cordis OptEase and TrapEase IVC filter injury cases nationwide. If you or somebody you know was injured by an IVC filter that broke or moved, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our law firm or call toll free 24 hours a day at 888-210-9693 ext. 2.